Invention Grant
- Patent Title: 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
-
Application No.: US16732536Application Date: 2020-01-02
-
Publication No.: US11173161B2Publication Date: 2021-11-16
- Inventor: Stephen Hitchcock , Betty Lam , Holger Monenschein , Holly Reichard
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K31/53
- IPC: A61K31/53 ; A61P25/18 ; C07D253/08
Abstract:
The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula 1: which are agonists of GPR139, certain compounds encompassed by formula 1, pharmaceutical compositions thereof, processes for making the compounds, and intermediates thereof.
Information query
